Literature DB >> 20639348

Parents' experiences of what comforts them when their child is suffering from cancer.

Charlotte Angström-Brännström1, Astrid Norberg, Gunilla Strandberg, Anna Söderberg, Vera Dahlqvist.   

Abstract

The aim of the study was to describe parents' narratives concerning what they find comforting when they have a child suffering from cancer. Interviews were conducted with 9 parents--8 mothers and 1 father--of children aged 3 to 9 years who were admitted to a pediatric oncology ward and had undergone their first treatment. The findings showed that the parents derived comfort from being close to their child, perceiving the child's strength, feeling at home in the ward, being a family and being at home, and receiving support from their social network. Comfort experienced in communion with the child and others became important and helped the parents build a new normality perceived as being at home in life despite all their difficulties. Within the frame of communion, the parents seemed to experience moments of hope for their child's recovery and survival.

Entities:  

Mesh:

Year:  2010        PMID: 20639348     DOI: 10.1177/1043454210364623

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  3 in total

1.  How Older Adults with Chronic Pain Manage Social Support Interactions with Mobile Media.

Authors:  Pamara F Chang; Natalya N Bazarova; Elaine Wethington
Journal:  Health Commun       Date:  2020-11-08

2.  Predictors of stress of parents of a child with cancer: a Jordanian perspective.

Authors:  Rami Masa'Deh; Jacqueline Collier; Carol Hall; Fadwa Alhalaiqa
Journal:  Glob J Health Sci       Date:  2013-09-04

3.  Children Undergoing Radiotherapy: Swedish Parents' Experiences and Suggestions for Improvement.

Authors:  Charlotte Ångström-Brännström; Gunn Engvall; Tara Mullaney; Kristina Nilsson; Gun Wickart-Johansson; Anna-Maja Svärd; Tufve Nyholm; Jack Lindh; Viveca Lindh
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.